5 Einträge gefunden

1. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

   1. Lüftner, Diana
   2. Hartkopf, Andreas D
   3. Lux, Michael P
   4. Overkamp, Friedrich
   5. Tesch, Hans
   6. Titzmann, Adriana
   7. Pöschke, Patrik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Clinical endpoints in real-world registry studies:PRAEGNANT network for women with advanced breast cancer, Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom

   1. Hartkopf, Andreas D.
   2. Emons, Julius
   3. Lux, Michael P.
   4. Taran, Florin Andrei
   5. Overkamp, Friedrich
   6. Tesch, Hans
   7. Titzmann, Adriana

   2020 - Forschungsinformationssystem des UKE
5. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE